Please login to the form below
Immodulon
This page shows the latest Immodulon news and features for those working in and with pharma, biotech and healthcare.
Latest appointments
-
Immodulon Therapeutics bolsters senior team
Independent biopharmaceutical company Immodulon Therapeutics has appointed Dr Jerome Zeldis as its executive vice chairman. ... the continued clinical development and commercialisation of Immodulon’s lead immunotherapy compound IMM-101”.
-
Immodulon Therapeutics appointments two new board of directors
Anthony Bolton and Sir Simon Robertson join the biopharma firm. Immodulon Therapeutics, a privately held, late-stage biopharmaceutical company focused on immuno-oncology has made two new senior appointments to its ... Anthony Bolton, one of the UK's most
More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- AstraZeneca and Innate Pharma to end study on immuno-oncology drug monalizumab
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- bluebird bio reveals plans to launch two gene therapies
- Roche’s Tecentriq demonstrates positive phase 3 results as a subcutaneous injection
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Strategic commitment
- Pfizer set to acquire Global Blood Therapeutics in deal worth $5.4bn
- AstraZeneca and Daiichi Sankyo get FDA approval for breast cancer drug
- NHS England launches hepatitis C screening scheme to reach 2030 elimination goal
- Bayer’s Nubeqa receives FDA approval to treat metastatic prostate cancer
- Valneva and Pfizer initiate phase 3 Lyme disease vaccine study
- Medmeme appoints Dr Joseph Laudano to medical affairs role
- Gilead announces positive Biktarvy data for HIV and hepatitis B
- Roche’s Tecentriq demonstrates positive phase 3 results as a subcutaneous injection
- Sarepta to submit application for Duchenne muscular dystrophy gene therapy
- Achieving communication excellence by targeting the right channel at the right time
- Successful product commercialisation: what can we learn from the rare disease setting?
PMHub
Videum Health
Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...
Latest intelligence
- Strategic commitment
- ...
- KOL Ambassador Program & Podcast Creation: A Customer Story
- ...
- Animation: Living With
- The journey from the patient's perspective...
